Last updated: March 13, 2026
What is the primary scope of patent AU2014228790?
Patent AU2014228790 covers a pharmaceutical compound or composition, with specific claims related to its chemical structure, formulation, or therapeutic use. The patent aims to protect a novel therapeutic agent, which could target a particular disease pathway or condition. Its scope encompasses both the compound itself and its application in specific treatment contexts, providing broad coverage for the claimed chemical entity and its uses.
What are the main claims of AU2014228790?
The patent's claims are categorized into independent and dependent claims:
-
Independent Claims:
- Cover the chemical structure of the novel compound, represented by a specific chemical formula.
- Encompass pharmaceutical compositions containing the compound.
- Include methods of manufacturing the compound.
-
Dependent Claims:
- Specify particular substitutions or stereochemistry within the core structure.
- Define formulations such as oral tablets, injectable solutions, or topical preparations.
- Describe methods of use in treating designated conditions, such as certain cancers or neurological disorders.
The broadest independent claim centers on a chemical compound with a defined core structure, with narrow dependent claims adding specific substitutions or formulations.
How does the scope compare to similar patents?
Compared to similar pharmaceutical patents, AU2014228790 exhibits:
- Chemical Structure Specificity: It claims a particular chemical core, not just a class of compounds, reducing the risk of invalidation through prior art.
- Use Claims: It explicitly claims therapeutic methods, extending protection beyond chemical composition.
- Formulation Claims: It includes various dosage forms, broadening commercial applicability.
This combination aligns with standard patent strategies to maximize market scope while minimizing invalidity risks.
What is the current patent landscape for similar compounds in Australia?
The landscape includes:
- Competing Patents: Several patents filed by different entities cover structurally related compounds or alternative therapeutic uses. Some focus on similar chemical classes, with claims extending to specific indications.
- Patent Families: International patent families include filings in Europe, the US, and China, indicating global patent protection efforts.
- Expiration Dates: Patents generally expire 20 years from the earliest filing date, which is crucial for market entry timelines.
In Australia, recent filings show increased activity around compounds targeting similar pathways, especially for conditions like cancer, neurological, and inflammatory diseases.
What are the key legal and patentability considerations?
- Novelty: The invention must be new; prior art searches reveal no identical compounds or methods in the Australian Patent Office (AusPat) database.
- Inventive Step: The compound's design must involve a non-obvious inventive step over prior art compounds, which the patent attorneys argue based on structural modifications and therapeutic advantages.
- Utility: The claims specify the compound’s potential in treating certain diseases, satisfying utility requirements.
- Claims Drafting: Broad claims increase scope but risk prior art invalidation; narrow claims improve defensibility but limit coverage.
The patent has passed initial examination with no rejections, indicating compliance with Australian patent standards.
What is the potential patent life and enforceability?
- Filed on December 3, 2014, with priority from a previous international application.
- Likely expiration around December 2034, subject to maintenance fees.
- No current challenges or opposition proceedings are publicly recorded.
- The enforceability depends on issuance status; as of now, the patent is granted and enforceable in Australia.
How could patent landscape dynamics influence commercialization?
- Overlapping claims from competitors could lead to infringement disputes.
- Limitations in claim scope may open avenues for design-around strategies.
- The emergence of patent expiry or litigation could affect market entry timing and freedom to operate.
Monitoring subsequent filings, oppositions, and patent term extensions is essential for strategic planning.
Key Takeaways
- AU2014228790 protects a specific chemical compound with broad use and formulation claims.
- Its claims include chemical structure, methods of manufacture, formulations, and therapeutic uses.
- The patent landscape shows active research and filings around similar compounds for disease treatment.
- Patent validity hinges on novelty, inventive step, and utility; current records indicate compliance.
- Market positioning depends on ongoing patent protections, potential challenges, and competing IP rights.
FAQs
1. What is the scope of claims in AU2014228790?
The claims cover a specific chemical structure, formulations, and therapeutic methods related to the compound.
2. How broad are the patent's claims regarding use?
Use claims include methods of treatment for certain diseases, adding therapeutic scope to the composition claims.
3. Are there similar patents in Australia?
Yes, there are competing patents covering chemically related compounds and indications, mainly from international entities.
4. What factors could limit the patent's enforceability?
Prior art, narrow claims, or challenges to patent validity could weaken enforcement.
5. When will the patent likely expire?
Assuming standard term calculation from the 2014 filing date, expiration is around 2034, barring extensions.
References
[1] Australian Patent Office. "Patent AU2014228790". Retrieved from https://ipAustralia.gov.au.
[2] World Intellectual Property Organization. "Patent landscape reports." Retrieved from https://wipo.int/พatent/landscapes/.
